Insmed Incorporated (NASDAQ:INSM) Receives $94.00 Consensus PT from Brokerages

Insmed Incorporated (NASDAQ:INSM – Get Free Report) has earned a consensus rating of “Buy” from the sixteen analysts that are currently covering the company, MarketBeat reports. Sixteen equities research analysts have rated the stock with a buy recommendation. The average twelve-month target price among brokerages that have updated their coverage on the stock in the […]